Showing results (21-30 of 451) with videos related to
Sort By:
Pageof 46
International Journal of Cancer|October 15, 1988
Differential lysis of melanoma clones by autologous recombinant interleukin 2-activated lymphocytes. Relationship with spontaneous resistance to doxorubicin (Dx)C Gambacorti-Passerini, L Rivoltini, R Supino, et al.Cancer Research|June 1, 1991
Inhibition of proliferation by c-myb antisense oligodeoxynucleotides in colon adenocarcinoma cell lines that express c-mybC Melani, L Rivoltini, G Parmiani, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1996
Multiple melanoma-associated epitopes recognized by HLA-A3-restricted CTLs and shared by melanomas but not melanocytesA Mazzocchi, W J Storkus, C Traversari, et al.Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|September 1, 1996
Differences in frequency distribution of HLA-A2 subtypes between North American and Italian white melanoma patients: relevance for epitope specific vaccination protocolsM A Player, K C Barracchini, T B Simonis, et al.International Journal of Cancer|October 15, 1990
Modulation of multidrug resistance by verapamil or mdr1 anti-sense oligodeoxynucleotide does not change the high susceptibility to lymphokine-activated killers in mdr-resistant human carcinoma (LoVo) lineL Rivoltini, M P Colombo, R Supino, et al.The Journal of Clinical Investigation|June 24, 1998
beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanomaD J Hicklin, Z Wang, F Arienti, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1998
Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killingL Rivoltini, M Radrizzani, P Accornero, et al.Cancer Metastasis Reviews|December 1, 1988
Susceptibility of human and murine drug-resistant tumor cells to the lytic activity of rIL2-activated lymphocytes (LAK)C Gambacorti-Passerini, L Rivoltini, M Radrizzani, et al.Tumori|December 31, 1990
Local adoptive immunotherapy of advanced head and neck tumors with LAK cells and interleukin-2M Squadrelli-Saraceno, L Rivoltini, G Cantù, et al.Experimental and Clinical Immunogenetics|January 1, 1990
H-2 class I gene analysis in 3-methylcholanthrene-induced murine fibrosarcomasC Castelli, F Mazzucchelli, M Sensi, et al.Pageof 46